PCBD Checklist Test License Terms & Conditions

License Instructions

This is a legal agreement between you and The Regents of the University of California ("Regents") By clicking on the 'I Agree to the License Terms' button at the end of this Agreement, you agree to be bound by the terms of this Non-Exclusive License Agreement. Even if you bypass the 'I Agree' button but start using The Persistent Complex Bereavement Disorder (PCBD) Checklist — Youth Version: Test and Administration Manual you will still be bound by the terms of this Non-Exclusive License Agreement. If you do not agree with the terms of this Agreement, please do not use the instrument or click further in this Agreement.

This Agreement is for use of The Persistent Complex Bereavement Disorder (PCBD) Checklist — Youth Version: Test and Administration Manual in an educational, research, clinical, or non-profit setting. 

For all other licensing inquiries please contact:  UCLA TDG: innovation@tdg.ucla.edu or by phone: 310-794-0558

1. Definitions. The following definitions apply herein:

  • (a) "Licensee" or, alternatively "You" means the individual or entity who is accepting this Agreement by clicking on the 'I Agree' button.
  • (b) "Licensed Products" means "The Persistent Complex Bereavement Disorder (PCBD) Checklist — Youth Version: Test and Administration Manual" (UCLA Case No. 2015-122) (the "Work"), which was made in the course of research at the University of California, Los Angeles by Dr. Christopher Layne, Dr. Julie Kaplow, and Dr. Robert Pynoos (the Authors), and is claimed in Regents' Copyright Rights and is generally referred to as the "PCBD Checklist".
  • (c) "Derivative Work(s)" means any changes, revision, enhancement, modification, translation, abridgement, condensation, or expansion created by Licensee that is based upon the Work or a portion thereof that would be a copyright infringement if prepared without the authorization of the copyright owners of the Work, or portion thereof.
  • (d) "User Limitations" means the way the PCBD Checklist or Work can be used by the user, as set forth below:
    • a. Maximum number of copies of the Licensed Products – see Appendix A or site license.
  • (e) "License Fee" is a payment calculated in accordance with the table below in section 2.

 

2. Limited License Grant

The Persistent Complex Bereavement Disorder (PCBD) Checklist — Youth Version: Test and Administration Manual instrument is licensed to you for a period of one year, to commence when the Licensee clicks the "I agree to the license terms" box, under the terms of this Agreement and subject to these User Limitations:

  • a. Field of use – Use only in the Health Services sector, including psychotherapeutic clinical settings; hospital, palliative, and hospice care settings; school-based settings including classroom-based risk screening and student health clinics; grief counseling settings; community-based bereavement support settings; internal quality assurance; community-based epidemiology applications; and for university-based and IRB-approved research applications.
  • b. No electronic versions – You may not make any electronic versions of the work without prior written permission although you may incorporate the instrument, in its entirety, into an electronic health records system.
  • c. No Translations – There are no translations allowed of the Work without prior written written consent by the first author, who can be contacted at CMLayne@mednet.ucla.edu (some translated versions may already exist, so please contact us first if one is needed). UC Regents retains copyright over all translated versions.
  • d. Internal use only – no distribution to external, non-affiliated entities.
  • e. No independent analyses of psychometric properties of the PCBD Checklist are permitted without the prior written consent and involvement of the authors. “Psychometric analyses” in this context refers to evaluate and determine the internal structure and validity of the PCBD Checklist test items using such statistical tools as exploratory or confirmatory factor analysis; item response theory; and indicators of predictive validity, incremental predictive validity, and convergent and/or discriminant validity. Parties interested in conducting a psychometric study should first contact the first author at CMLayne@mednet.ucla.edu.

 

Subject to the terms, and conditions of the Agreement, the Regents hereby grants to you the non-exclusive right to copy and distribute the Licensed Products, subject to the User Limitations listed above.

  • Licensee shall not have the right to create Derivative Works of the Licensed Products.
  • Licensee shall not have the right to sublicense, sell, transfer, or assign the Licensed Products.
  • Licensee shall not permit the Licensed Products to be used by parties outside Licensee's organization or outside the User Limitations.
  • Licensee shall not alter the Licensed Products without the prior written consent of Licensor, other than to add its own instructions to the instrument as long as the added instructions do not alter any of the existing text of the Licensed Products.
  • If translations of the Licensed Products are needed, please contact the first author at CMLayne@mednet.ucla.edu before commencing any work.
  • Licensee shall not undertake or seek to publish any independent psychometric analyses of the PCBD Checklist without prior written consent by the first author, who can be contacted at CMLayne@mednet.ucla.edu.

 

The Regents reserves all rights not expressly granted to you under this Agreement.

Fees. In consideration for the License, Licensee will pay to The Regents a fee, non-creditable, non-refundable license issue fee as determined by the number of administrations that will be done in a yearly period and based on the rates quoted below.

Estimated Number of Instruments/ Number of Administrations/year

Cost

Individual clinician or counselor use up to 25 total administrations, or limited use research study for thesis/doctoral program

$25.00 flat fee

26 - 100

$75.00 flat fee

101 - 200

$150.00 flat fee

201 - 400

$250.00 flat fee

Over 400 or other special circumstances

Please contact innovation@tdg.ucla.edu. Discounts may be available for federal, state, county, and agency-wide uses.

 

3. Care for Data

You will use reasonable care in keeping the Licensed Products confidential; using at least the same degree of care you exercise in protecting your own proprietary information of a similar nature, but at a minimum reasonable care. You shall comply with all applicable federal and state laws regarding the confidentiality of health information, including the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") at all times.

4. Effective Date

This Agreement becomes effective the date that You click 'I Accept' ("Effective Date"). The Regents shall make the Licensed Products available for electronic delivery promptly following Your payment of the Licensing fee.

5. Support

All uses of the Licensed Products by Licensee will be by, and at, the sole expense of Licensee. Licensor may, at its sole discretion, offer limited support, future enhancements or upgrade versions to Licensee without cost or, for extended support, at a price that will be determined on a case-by-case basis.

6. Term and Termination

The rights and licenses granted herein shall continue for an initial term of one (1) year commencing on the Effective Date conditioned upon Licensee's payment of the License Fee within thirty (30) days after the Invoicing by The Regents; failure to pay the License Fee within thirty (30) days after Invoicing by The Regents will terminate this Agreement. The Agreement may be renewed for successive terms. This Agreement is also subject to termination by Licensor if Licensee becomes insolvent, declares bankruptcy, or a receiver or trustee is appointed for Licensee. In addition, either party may terminate this Agreement with written notice upon the occurrence of a default or breach by the other party in any of its obligations under this Agreement, provided such default or breach continues for more than thirty (30) days after receipt by such other party of notice; provided, however, there shall be no such cure period with respect to any breach of Licensee's obligation under Section 9 hereto. Upon termination of this Agreement under this Section 6, Licensee agrees to cease using the Licensed Products and to return all Licensed Copies of the Licensed Products to Licensor, or to certify to Licensor that it has destroyed all such Licensed Copies.

7. Limited Warranty

The Regents warrants that it has the lawful right to grant this license to Licensee.

This License and the associated Work are provided WITHOUT WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR ANY OTHER WARRANTY, EXPRESS OR IMPLIED.  THE REGENTS MAKES NO REPRESENTATION OR WARRANTY THAT ANY LICENSED PRODUCT WILL NOT INFRINGE ANY PATENT, COPYRIGHT, OR OTHER PROPRIETARY RIGHT.

Nothing in this Agreement will be construed as:

  • A warranty or representation by The Regents as to the validity or scope of any Regents' Patent or Copyright Rights:
    • A warranty or representation that anything made, used, sold or otherwise disposed of under any license granted in this Agreement is or will be free from infringement of patents or copyrights of third parties.
    • Obligating The Regents to bring or prosecute actions or suits against third parties for copyright or patent infringement.
    • Conferring by implication, estoppel or otherwise any license or rights under any intellectual property of The Regents other than Regents' Copyright Rights as defined herein.
    • Obligating The Regents to furnish any know-how not provided in Regents' Copyright Rights.

 

THE REGENTS WILL NOT BE LIABLE FOR ANY LOST PROFITS, COSTS OF PROCURING SUBSTITUTE GOODS OR SERVICES, LOST BUSINESS, ENHANCED DAMAGES FOR INTELLECTUAL PROPERTY INFRINGEMENT OR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR OTHER SPECIAL DAMAGES RESULTING FROM EXERCISE OF THIS LICENSE OR THE USE OF THE WORK OR LICENSED PRODUCTS. THE REGENTS WILL NOT BE LIABLE FOR ANY CAUSES OF ACTION OF ANY KIND (INCLUDING TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY AND BREACH OF WARRANTY) EVEN IF THE REGENTS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

8. Your Indemnity

Licensee will indemnify, hold harmless and defend The Regents, The Regents' officers, employees, and agents, the sponsors of the research that led to the Work, the authors of the work and their respective employers from and against any and all liability, claims, suits, losses, damages, costs, fees and expenses resulting from or arising out of exercise of this Agreement. Indemnification includes but is not limited to products liability. If The Regents, in its sole discretion, believes that there will be a conflict of interest or it will not otherwise be adequately represented by counsel chosen by Licensee to defend The Regents, then The Regents may retain counsel of its choice to represent it, and Licensee will pay all expenses for such representation.

9. Protection of Licensed Products

Except as expressly provided herein, You receive no rights to and will not sell, assign, lease, market, transfer, encumber, or otherwise allow any third person, firm, corporation, other entity to use, copy, or reproduce in whole or in part in any manner the Licensed Products. You shall insure that no unauthorized copy, in whole or in part, in any form shall be made of the Licensed Products. You shall not permit any user to modify any part of the Licensed Products.

10. Assignment

Except as expressly provided herein, You may not assign, sublicense, or otherwise transfer its rights, duties or obligations under this Agreement to any other party or entity, in whole or in part, without the prior written consent of The Regents.

11. Notices

Notices to Licensee shall be sent to the address specified beneath Licensee's signature below and to Licensor to:

  • The Regents of the University of California
  • University of California, Los Angeles
  • UCLA Technology Development Group
  • 10889 Wilshire Blvd, Suite 920
  • Los Angeles, CA 90095-7191
  • Attention: Director
  • Ref: UC Case No. 2015-122

 

Notice shall be effective (a) on the date of delivery if delivered in person, (b) five (5) days after mailing if mailed by first-class certified mail, postage paid, or (c) on the next business day if sent by overnight delivery. Either party may change its designated address by written notice.

12. Miscellaneous

(a) This Agreement embodies the entire understanding of the parties and supersedes all previous communications, representations or understandings, either oral or written, between the parties relating to the subject matter hereof. No modification or amendment to this Agreement will be valid or binding unless reduced to writing and duly executed by the party or parties to be bound thereby;

(b) Licensee will not use any name, trade name, trademark or other designation of The Regents' or its employees (including contraction, abbreviation or simulation of any of the foregoing) in advertising, publicity or other promotional activity. Unless required by law, Licensee is expressly prohibited from using the name "The Regents of the University of California" or the name of any campus of the University of California in advertising, publicity, or other promotional activity, without written permission of The Regents;

(c) THIS AGREEMENT IS TO BE INTERPRETED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA, but the scope and validity of any copyright will be governed by the applicable laws of the country of the copyright registration;

(d) The headings of the several sections are inserted for convenience of reference only and are not intended to be a part of, or to affect the meaning or interpretation of, this Agreement

(e)The waiver of any breach of any term of this Agreement does not waive any other breach of that or any other term.

(f) If any part of this Agreement is for any reason found to be unenforceable, all other parts nevertheless remain enforceable as long as a party's rights under this Agreement are not materially affected. In lieu of the unenforceable provision, the parties will substitute or add as part of this Agreement a provision that will be as similar as possible in economic and business objectives as was intended by the unenforceable provision.

(g) No provisions of this Agreement are intended or shall be construed to confer upon or give to any person or entity other than The Regents and the Licensee any rights, remedies or other benefits under, or by reason of, this Agreement.

(h) In performing their respective duties under this Agreement, each of the parties will be operating as an independent contractor. Nothing contained herein will in any way constitute any association, partnership, or joint venture between the parties hereto, or be construed to evidence the intention of the parties to establish any such relationship. Neither party will have the power to bind the other party or incur obligations on the other party's behalf without the other party's prior written consent.